Mapping the therapeutic landscape of CRISPR-Cas9 for combating age-related diseases

Qiyu He, Yida Wang, Zhimin Tan, Xian Zhang, Chao Yu, Xiaoqin JiangFrontiers in Genome Editing 2025 · DOI

TL;DR

This paper provides a comprehensive bibliometric analysis of CRISPR-Cas9 research focused on age-related diseases, mapping out key contributors, research trends, and technological advancements. It highlights the immense therapeutic potential of CRISPR-Cas9 for conditions like Alzheimer's and Parkinson's, while also detailing significant hurdles to clinical translation, such as off-target effects and delivery challenges.

What Problem Does This Paper Address?

The global population is aging, leading to a surge in age-related diseases like Alzheimer's, Parkinson's, and cardiovascular disorders. These conditions place a massive strain on healthcare systems. While CRISPR-Cas9 technology offers a revolutionary approach to tackle these diseases by precisely editing genes, the research landscape is fragmented. There's a need for a consolidated understanding of the current state of CRISPR-Cas9 research in this domain, including its successes, limitations, and future directions, to accelerate its translation into effective therapies.

Methods

The study employed a bibliometric analysis approach. This involved:

  • Data Retrieval: Comprehensive searches were conducted across major databases (PubMed, Embase, Cochrane Library, Scopus, Web of Science) for studies published between January 1, 2005, and December 31, 2024, focusing on CRISPR-Cas9 and age-related diseases.
  • Study Selection: Rigorous inclusion and exclusion criteria were applied by two independent reviewers to select relevant original articles.
  • Data Analysis: Bibliometric information (publications, citations, countries, institutions, authors, journals, keywords) was extracted and analyzed.
  • Visualization and Analysis Tools:
    • CiteSpace: Used for co-occurrence analysis of countries, authors, institutions, and co-cited references to create visual maps of research networks and identify hotspots. It also facilitated keyword burst detection.
  • Python (v3.10.12) with Geopandas and Matplotlib: Used for generating global distribution and collaboration maps.
  • Excel: Employed for modeling publication growth trends.
  • Cluster Analysis: An unsupervised learning algorithm was used to identify patterns and groupings within the data.

Datasets

Not discussed in the paper. The study analyzed existing published literature from major scientific databases.

Key Insights and Ideas

  • Global Research Dominance: The United States and China are clear leaders in CRISPR-Cas9 research for age-related diseases, contributing a significant portion of publications.
  • Collaborative Clusters, but Limited Interconnection: While strong collaborations exist within specific research groups and institutions, there's a notable lack of broader intergroup collaboration, suggesting potential regional or disciplinary barriers that could be overcome.
  • Evolution of Research Focus: The research has evolved from foundational CRISPR mechanism studies to disease-specific applications, and more recently, to clinical translation and therapeutic implementation, as evidenced by the shift in publication venues.
  • Key Disease Targets: Alzheimer's disease, Parkinson's disease, cardiovascular disorders, and osteoporosis are prominent targets for CRISPR-Cas9 interventions.
  • Delivery is a Major Hurdle: Keyword burst analysis highlights "Transplantation" and "In vivo" as significant areas of focus, underscoring the ongoing challenge of effectively delivering CRISPR components to target tissues.
  • Ethical Considerations are Paramount: The paper explicitly mentions the ongoing ethical debates surrounding germline editing and the need for stringent oversight.

Key Results

  • Publication Growth: The field has experienced exponential growth, with a fitting formula indicating a strong upward trend in publications.
  • Citation Impact: The research area has garnered significant attention, with a total of 23,835 citations and an H-index of 73.
  • Geographic Distribution: Research is distributed across 73 countries, with the US and China leading. Germany, England, and France also show significant influence.
  • Top Contributors: The United States and China are home to the leading authors and institutions in this field.
  • Core Journals: Publications are concentrated in high-impact Q1 and Q2 journals specializing in molecular biology, genetics, and aging research, reflecting the interdisciplinary nature of the field.
  • Keyword Hotspots: Keyword clustering identified key themes including Alzheimer's disease, Parkinson's disease, gene editing, and cellular senescence.
  • Therapeutic Innovations: Table 2 details various CRISPR-based therapeutic innovations for specific age-related diseases, outlining application areas, research advances, mechanisms, delivery systems, and model organisms.

Limitations and Future Work

Limitations:

  • Scope of Data: The study acknowledges potential incompleteness due to the exclusion of regional studies and non-English literature.
  • Depth of Technical Analysis: While challenges are identified, the paper notes limited exploration of the molecular mechanisms behind these issues and cutting-edge solutions.

Future Work:

  • Enhanced Precision: Development of high-precision Cas9 variants and AI-guided sgRNA design to minimize off-target effects.
  • Improved Delivery: Focus on efficient and tissue-specific delivery systems, potentially through viral vector optimization and advanced non-viral approaches (e.g., functionalized nanoparticles).
  • HDR-Independent Tools: Further development of tools like prime editing to overcome limitations in editing non-dividing cells.
  • Ethical and Regulatory Frameworks: Establishment of robust international ethical guidelines and regulatory frameworks for germline editing.
  • Clinical Translation: Emphasis on multicenter clinical trials to gather long-term safety and efficacy data.
  • Broader Data Inclusion: Future studies should incorporate regional databases and open-access resources for more comprehensive global coverage.
  • Experimental Validation: Integrating experimental data and disease-specific models to validate proposed strategies.

Summary updated

Abstract

CRISPR-Cas9 (clustered regularly interspaced short palindromic repeats-associated protein 9) has emerged as a transformative genome-editing tool with significant therapeutic potential for age-related diseases, including Alzheimer's disease, Parkinson's disease, cardiovascular disorders, and osteoporosis. This study presents a bibliometric analysis of CRISPR-Cas9 research in age-related diseases, identifying key contributors, major research hotspots, and critical technological advancements. While promising applications have been demonstrated in gene repair, functional regulation, and molecular interventions, significant barriers persist, including off-target effects, low delivery efficiency, and limited editing in non-dividing cells. Ethical concerns over germline editing and gaps in long-term safety data further complicate clinical translation. Future directions emphasize the development of high-precision Cas9 variants, homology-directed repair-independent tools, and efficient delivery systems, alongside the establishment of international regulatory frameworks and multicenter clinical trials. These efforts are essential to fully realize the potential of CRISPR-Cas9 in addressing the global health challenges of aging.
BibTeX
@inproceedings{he2025mapping,
  author = {Qiyu He and Yida Wang and Zhimin Tan and Xian Zhang and Chao Yu and Xiaoqin Jiang},
  title = {{Mapping the therapeutic landscape of CRISPR-Cas9 for combating age-related diseases}},
  booktitle = {Frontiers in Genome Editing},
  year = {2025},
  doi = {10.3389/fgeed.2025.1558432},
}
Figure